Seminars in Pediatric Surgery
Volume 14, Issue 3 , Pages 159-166 , August 2005

Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis

  • Jeffrey S. Upperman

      Affiliations

    • Department of Surgery, University of Pittsburgh and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylania
    • Corresponding Author InformationAddress reprint requests and correspondence: Jeffrey S. Upperman, MD, Children's Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213
    • ,
  • Douglas Potoka

      Affiliations

    • Department of Surgery, University of Pittsburgh and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylania
    • ,
  • Anatoly Grishin

      Affiliations

    • Department of Surgery, Keck School of Medicine, University of Southern California, Children's Hospital Los Angeles, Los Angeles, California
    • ,
  • David Hackam

      Affiliations

    • Department of Surgery, University of Pittsburgh and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylania
    • ,
  • Ruben Zamora

      Affiliations

    • Department of Surgery, University of Pittsburgh and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylania
    • ,
  • Henri R. Ford

      Affiliations

    • Department of Surgery, Keck School of Medicine, University of Southern California, Children's Hospital Los Angeles, Los Angeles, California

References 

  1. Viscardi RM , Lyon NH , Sun CC , et al.  Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine . Pediatr Pathol Lab Med . 1997;17(4):547–559
  2. Ford H , Watkins S , Reblock K , et al.  The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis . J Pediatr Surg . 1997;32(2):275–282
  3. Ford HR , Sorrells DL , Knisely AS . Inflammatory cytokines, nitric oxide, and necrotizing enterocolitis . Semin Pediatr Surg . 1996;5(3):155–159
  4. Nadler EP , Dickinson E , Knisely A , et al.  Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis . J Surg Res . 2000;92(1):71–77
  5. Dvorak B , Halpern MD , Holubec H , et al.  Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model . Pediatr Res . 2003;53(3):426–433
  6. Di Lorenzo M , Bass J , Krantis A . Use of L-arginine in the treatment of experimental necrotizing enterocolitis . J Pediatr Surg . 1995;30(2):235–240 ; discussion 240-1.
  7. Di Lorenzo M , Krantis A . Altered nitric oxide production in the premature gut may increase susceptibility to intestinal damage in necrotizing enterocolitis . J Pediatr Surg . 2001;36(5):700–705
  8. Ford H , Reblock K , Teramana C , et al.  The role of nitric oxide in the pathogenesis of necrotizing enterocolitis . Surg Forum . 1995;46:642–644
  9. MacKendrick W , Caplan M , Hsueh W . Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat . Pediatr Res . 1993;34(2):222–228
  10. Potoka DA , Nadler EP , Upperman JS , et al.  Role of nitric oxide and peroxynitrite in gut barrier failure . World J Surg . 2002;26(7):806–811
  11. Upperman JS, Nadler EP, Hoffman R, et al. Peroxynitrite (ONOO) induces enterocyte apoptosis in vitro by modulating mitochondrial membrane potential and pars cleavage. In: American College of Surgeons Clinical Congress. San Francisco, CA: American College of Surgeons, 1999.
  12. Potoka DA , Upperman JS , Zhang XR , et al.  Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro . Am J Physiol Gastrointest Liver Physiol . 2003;285(5):G861–G869
  13. Nathan C , Xie Q . Nitric oxide synthases: roles, tolls, and controls . Cell . 1994;78:915–918
  14. Beckman JS , Koppenol WH . Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly . Am J Physiol . 1996;271(5 Pt 1):C1424–C1437
  15. Kong SK , Yim MB , Stadtman ER , et al.  Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide . Proc Natl Acad Sci U S A . 1996;93(8):3377–3382
  16. Gow AJ , Duran D , Malcolm S , et al.  Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation . FEBS Lett . 1996;385(1-2):63–66
  17. Radi R , Beckman JS , Bush KM , et al.  Peroxynitrite oxidation of sulfhydryls . The cytotoxic potential of superoxide and nitric oxide. J Biol Chem . 1991;266(7):4244–4250
  18. Radi R , Beckman J , Bush K , et al.  Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide . Arch Biochem Biophys . 1991;288(2):481–487
  19. Tepperman BL , Brown JF , Whittle BJ . Nitric oxide synthase induction and intestinal epithelial cell viability in rats . Am J Physiol . 1993;265(2 Pt 1):G214–G218
  20. Hoffman RA , Zhang G , Nussler NC , et al.  Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa . Am J Physiol . 1997;272(2 Pt 1):G383–G392
  21. Chen K , Inoue M , Okada A . Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury . Biochem Biophys Res Commun . 1996;224(3):703–708
  22. Dignass AU , Podolsky DK , Rachmilewitz D . NO chi generation by cultured small intestinal epithelial cells . Dig Dis Sci . 1995;40(9):1859–1865
  23. Cook HT , Bune AJ , Jansen AS , et al.  Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat . Clin Sci (Colch) . 1994;87(2):179–186
  24. Barry M , Aloisi J , Pickering S , et al.  Nitric oxide modulates water and electrolyte transport in the ileum . Ann Surg . 1994;219:382–388
  25. Kubes P . Nitric oxide modulates epithelial permeability in the feline small intestine . Am J Physiol . 1992;262:G1138–G1142
  26. Kanwar S , Wallace J , Befus D , et al.  Nitric oxide synthesis inhibition increases epithelial permeability via mast cells . Am J Physiol . 1994;266:G222–G229
  27. Hutcheson IR , Whittle BJ , Boughton-Smith NK . Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat . Br J Pharmacol . 1990;101(4):815–820
  28. Brunelli L , Crow JP , Beckman JS . The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli . Arch Biochem Biophys . 1995;316(1):327–334
  29. De Groote MA , Fang FC . NO inhibitions: antimicrobial properties of nitric oxide . Clin Infect Dis . 1995;21(suppl 2):S162–S165
  30. Miller MJ , Sadowska-Krowicka H , Chotinaruemol S , et al.  Amelioration of chronic ileitis by nitric oxide synthase inhibition . J Pharmacol Exp Ther . 1993;264(1):11–16
  31. Luo CC , Chen HM , Chiu CH , et al.  Effect of N(G)-nitro-L-arginine methyl ester on intestinal permeability following intestinal ischemia-reperfusion injury in a rat model . Biol Neonate . 2001;80(1):60–63
  32. Ciftci I , Dilsiz A , Aktan TM , et al.  Effects of nitric oxide synthase inhibition on intestinal damage in rats with experimental necrotizing enterocolitis . Eur J Pediatr Surg . 2004;14(6):398–403
  33. Sorrells DL , Friend C , Koltuksuz U , et al.  Inhibition of nitric oxide with aminoguanidine reduces bacterial translocation after endotoxin challenge in vivo . Arch Surg . 1996;131(11):1155–1163
  34. Unno N , Wang H , Menconi MJ , et al.  Inhibition of inducible nitric oxide synthase ameliorates endotoxin- induced gut mucosal barrier dysfunction in rats [see comments] . Gastroenterology . 1997;113(4):1246–1257
  35. Chen LW , Hsu CM , Wang JS , et al.  Specific inhibition of iNOS decreases the intestinal mucosal peroxynitrite level and improves the barrier function after thermal injury [In Process Citation] . Burns . 1998;24(8):699–705
  36. Dickinson E , Tuncer R , Nadler E , et al.  NOX, A nitric oxide scavenger reduces bacterial translocation in rats after endotoxemia by decreasing enterocyte apoptosis . Am J Physiol . 1999;277:G1281–G1287
  37. Mishima S , Xu D , Lu Q , et al.  Bacterial translocation is inhibited in inducible nitric oxide synthase knockout mice after endotoxin challenge but not in a model of bacterial overgrowth . Arch Surg . 1997;132(11):1190–1195
  38. MacMicking JD , Nathan C , Hom G , et al.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [published erratum appears in Cell 1995;81(7):following 1170] . Cell . 1995;81(4):641–650
  39. Boughton-Smith NK , Evans SM , Hawkey CJ , et al.  Nitric oxide synthase activity in ulcerative colitis and Crohn's disease . Lancet . 1993;342(8867):338–340
  40. Singer II , Kawka DW , Scott S , et al.  Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease . Gastroenterology . 1996;111(4):871–885
  41. Ford H , Watkins S , Reblock K , et al.  The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis . J Pediatr Surg . 1997;32(2):275–282
  42. Mannick EE , Bravo LE , Zarama G , et al.  Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants . Cancer Res . 1996;56(14):3238–3243
  43. Lin KT , Xue JY , Nomen M , et al.  Peroxynitrite-induced apoptosis in HL-60 cells . J Biol Chem . 1995;270(28):16487–16490
  44. Sandoval M , Zhang XJ , Liu X , et al.  Peroxynitrite-induced apoptosis in T84 and RAW 264.7 cells: attenuation by L-ascorbic acid . Free Radic Biol Med . 1997;22(3):489–495
  45. Estevez AG , Radi R , Barbeito L , et al.  Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors . J Neurochem . 1995;65(4):1543–1550
  46. Potoka DA , Nadler EP , Zhou X , et al.  Inhibition of NF-kappaB by IkappaB prevents cytokine-induced NO production and promotes enterocyte apoptosis in vitro . Shock . 2000;14(3):366–373
  47. Potoka DA , Upperman JS , Nadler EP , et al.  NF-kappaB inhibition enhances peroxynitrite-induced enterocyte apoptosis . J Surg Res . 2002;106(1):7–14
  48. Upperman JS, Friend C, Nadler EP, et al. Peroxynitrite (PN) induces enterocyte apoptosis in vitro: implication for NO-mediated gut barrier failure. In: Fourth International Shock Congress. Philadelphia, PA: Shock Society, 1999.
  49. Nishikawa M , Takeda K , Sato EF , et al.  Nitric oxide regulates energy metabolism and Bcl-2 expression in intestinal epithelial cells . Am J Physiol . 1998;274(5 Pt 1):G797–G801
  50. Salzman AL , Menconi MJ , Unno N , et al.  Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers . Am J Physiol . 1995;268(2 Pt 1):G361–G373
  51. Clementi E , Brown GC , Feelisch M , et al.  Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione . Proc Natl Acad Sci U S A . 1998;95(13):7631–7636
  52. Lizasoain I , Moro MA , Knowles RG , et al.  Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose . Biochem J . 1996;314(Pt 3):877–880
  53. Richter C , Schweizer M , Cossarizza A , et al.  Control of apoptosis by the cellular ATP level . FEBS Lett . 1996;378(2):107–110
  54. Green DR , Reed JC . Mitochondria and apoptosis . Science . 1998;281(5381):1309–1312
  55. Li P , Nijhawan D , Budihardjo I , et al.  Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade . Cell . 1997;91(4):479–489
  56. Enari M , Sakahira H , Yokoyama H , et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [see comments] [published erratum appears in Nature 1998;393(6683):396] . Nature . 1998;391(6662):43–50
  57. Nicholson DW , Thornberry NA . Apoptosis. Life and death decisions . Science . 2003;299(5604):214–215
  58. Thornberry NA , Lazebnik Y . Caspases: enemies within . Science . 1998;281(5381):1312–1316
  59. Virag L , Szabo C . Inhibition of poly(ADP-ribose) synthetase (PARS) and protection against peroxynitrite-induced cytotoxicity by zinc chelation . Br J Pharmacol . 1999;126(3):769–777
  60. Virag L , Szabo C . BCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death . Free Radic Biol Med . 2000;29(8):704–713
  61. Podolsky DK . Regulation of intestinal epithelial proliferation: a few answers, many questions . Am J Physiol . 1993;264(2 Pt 1):G179–G186
  62. Tarnawski AS , Jones MK . The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF- R signal transduction pathways . J Clin Gastroenterol . 1998;27(suppl 1):S12–S20
  63. van der Geer P , Hunter T , Lindberg RA . Receptor protein-tyrosine kinases and their signal transduction pathways . Annu Rev Cell Biol . 1994;10:251–337
  64. Schwartzberg PL . The many faces of Src: multiple functions of a prototypical tyrosine kinase . Oncogene . 1998;17(11 Reviews):1463–1468
  65. Corey SJ , Anderson SM . Src-related protein tyrosine kinases in hematopoiesis . Blood . 1999;93(1):1–14
  66. Davis RJ . The mitogen-activated protein kinase signal transduction pathway . J Biol Chem . 1993;268(20):14553–14556
  67. Pigazzi A , Heydrick S , Folli F , et al.  Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets . J Biol Chem . 1999;274:14368–14375
  68. Kinobe R , Ji Y , Nakatsu K . Peroxynitrite-mediated inactivation of heme oxygenases . BMC Pharmacol . 2004;4(1):26
  69. Nomiyama T , Igarashi Y , Taka H , et al.  Reduction of insulin-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor substrate-1 . Biochem Biophys Res Commun . 2004;320(3):639–647
  70. Uc A , Kooy NW , Conklin JL , et al.  Peroxynitrite inhibits epidermal growth factor receptor signaling in Caco-2 cells . Dig Dis Sci . 2003;48(12):2353–2359
  71. Kelly N , Friend K , Boyle P , et al.  The role of the glutathione antioxidant system in gut barrier failure in a rodent model of experimental necrotizing enterocolitis . Surgery . 2004;136(3):557–566
  72. Upperman JS, DeAlmeida D, Wong C, et al. Network gene expression analysis of experimental necrotizing enterocolitis (NEC). In: 3rd Annual Symposium on Necrotizing Enterocolitis. Columbus, OH, 2005.
  73. Braun N , Michel U , Ernst BP , et al.  Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production . Neurosci Lett . 1996;215(2):75–78
  74. Kroeger KM , Carville KS , Abraham LJ . The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription . Mol Immunol . 1997;34(5):391–399
  75. Bouma G , Crusius JB , Oudkerk Pool M , et al.  Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles . Relevance for inflammatory bowel disease. Scand J Immunol . 1996;43(4):456–463
  76. Louis E , Franchimont D , Piron A , et al.  Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans . Clin Exp Immunol . 1998;113(3):401–406
  77. Gray PW , Goeddel DV . Structure of the human immune interferon gene . Nature . 1982;298(5877):859–863
  78. Perrey C , Pravica V , Sinnott PJ , et al.  Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report . Transplant Immunol . 1998;6(3):193–197
  79. Fishman D , Faulds G , Jeffery R , et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis . J Clin Invest . 1998;102(7):1369–1376
  80. Koss K , Satsangi J , Fanning GC , et al.  Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies . Genes Immun . 2000;1(3):185–190
  81. Louis E , Satsangi J , Roussomoustakaki M , et al.  Cytokine gene polymorphisms in inflammatory bowel disease . Gut . 1996;39(5):705–710
  82. Nemetz A , Nosti-Escanilla MP , Molnar T , et al.  IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease . Immunogenetics . 1999;49(6):527–531
  83. Stokkers PC , Camoglio L , van Deventer SJ . Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy . J Inflamm . 1995;47(1-2):97–103
  84. Klein W , Tromm A , Griga T , et al.  Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases . Genes Immun . 2001;2(5):287–289
  85. Garcia-Gonzalez MA , Crusius JB , Strunk MH , et al.  TGFB1 gene polymorphisms and inflammatory bowel disease . Immunogenetics . 2000;51(10):869–872
  86. Cominelli F , Pizarro TT . Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease . Aliment Pharmacol Ther . 1996;10(suppl 2):49–53
  87. Aithal GP , Craggs A , Day CP , et al.  Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflammatory bowel disease . Dig Dis Sci . 2001;46(7):1520–1525
  88. Klein W , Tromm A , Griga T , et al.  The polymorphism at position-174 of the IL-6 gene is not associated with inflammatory bowel disease . Eur J Gastroenterol Hepatol . 2001;13(1):45–47
  89. Klein W , Tromm A , Griga T , et al.  The IL-10 gene is not involved in the predisposition to inflammatory bowel disease . Electrophoresis . 2000;21(17):3578–3582
  90. Fiorentino DF , Bond MW , Mosmann TR . Two types of mouse T helper cell . IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med . 1989;170(6):2081–2095
  91. Taga K , Tosato G . IL-10 inhibits human T cell proliferation and IL-2 production . J Immunol . 1992;148(4):1143–1148
  92. Fiorentino DF , Zlotnik A , Mosmann TR , et al.  IL-10 inhibits cytokine production by activated macrophages . J Immunol . 1991;147(11):3815–3822
  93. Turner DM , Williams DM , Sankaran D , et al.  An investigation of polymorphism in the interleukin-10 gene promoter . Eur J Immunogenet . 1997;24(1):1–8
  94. Lin HY , Lodish HF . Receptors for the TGF-beta superfamily: multiple polypeptides and serine/thereonin kinases . Trends Cell Biol . 1993;3:14–19
  95. Awad MR , El-Gamel A , Hasleton P , et al.  Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation . Transplantation . 1998;66(8):1014–1020
  96. Treszl A , Kocsis I , Szathmari M , et al.  Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis . Acta Paediatr . 2001;90(10):1182–1185
  97. Treszl A , Heninger E , Kalman A , et al.  Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis . J Pediatr Surg . 2003;38(9):1374–1378
  98. Lucentini J . Gene associations studies typically wrong . The Scientist . 2004;18(24):20
  99. Heresbach D , Alizadeh M , Bretagne JF , et al.  TAP gene transporter polymorphism in inflammatory bowel diseases . Scand J Gastroenterol . 1997;32(10):1022–1027

PII: S1055-8586(05)00032-6

doi: 10.1053/j.sempedsurg.2005.05.004

Seminars in Pediatric Surgery
Volume 14, Issue 3 , Pages 159-166 , August 2005

Article Tools